Pura Vida Investments, LLC Ngm Biopharmaceuticals Inc Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.41 - $12.93 $179,168 - $679,368	-52,542 Reduced 38.72%	83,154 $417,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $1.71 Million - $2.4 Million	135,696 New	135,696 $1.78 Million
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $580,972 - $782,483	-42,069 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $21,540 - $27,480	-1,248 Reduced 2.88%	42,069 $745,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $872,837 - $1.13 Million	43,317 New	43,317 $911,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.